New Insights on How Interleukin-33 Contributes to Skin and Pancreatic Cancers
Massachusetts General Hospital | February 23, 2021
The results suggest that inhibiting IL-33 in cancer-prone cells may help prevent cancers associated with inflammation
Pancreatic Cancer
New Map of the Immune Landscape in Pancreatic Cancer Could Guide Immunotherapy
Michigan Medicine - University of Michigan | October 28, 2020
The analysis highlights the diversity of immune responses in pancreatic cancer and the need for personalized treatments
New Experimental Blood Test Determines Which Pancreatic Cancers Will Respond to Treatment
Van Andel Research Institute | October 23, 2020
The blood test could help guide therapeutic decisions by detecting resistant cancers
Single-Cell RNA Sequencing Reveals More Detail in Pancreatic Tumors
The Translational Genomics Research Institute | September 30, 2020
TGen and HonorHealth investigators suggest this granular analysis could lead to better treatments for pancreatic cancer patients
Microbiome Profiling Could Improve Early Pancreatic Cancer Diagnosis
Miriam Bergeret, MSc | September 1, 2020
Recent research reveals a complex interaction between the microbiome and the immune system in pancreatic cancer
Type 3c Diabetes Could Be an Early Manifestation of Pancreatic Cancer
Spanish National Cancer Research Centre | May 13, 2020
Study finds that pancreatic cancer is the cause of diabetes type 3c in 26 percent of cases
Blood Test May Help Doctors Catch Pancreatic Cancer Early
University of Pennsylvania School of Medicine | April 16, 2020
Penn study shows liquid biopsy may be viable option for both diagnosis and disease staging
'Virtual Biopsy' Allows Doctors to Accurately Diagnose Precancerous Pancreatic Cysts
Ohio State University Wexner Medical Center | December 5, 2019
New method means doctors can eliminate precancerous cysts and potentially save lives
Pancreatic Cancer Tumor Classification Could Optimize Treatment Choices
UNC Lineberger Comprehensive Cancer Center | November 25, 2019
Researchers reported findings for how two subtypes of pancreatic cancer respond to treatments differently
Silencing RNA Nanotherapy Shows Promise against Pancreatic Cancer
University of South Florida | October 23, 2019
A Washington University/University of South Florida preclinical study finds that the novel nanoparticle delivers gene-level treatment to suppress KRAS-driven cancer without adverse effects